Spectra Plasmonics has developed a portable technology that can accurately identify added drugs, even at trace levels, and protect users from accidental overdoses. The tool requires minimal training to use and allows operators to detect fentanyl and other additives within minutes, enabling real-time data monitoring for communities to better tackle the crisis.
Location: Canada, Ontario, Kingston
Employees: 11-50
Founded date: 2017